eLaws | eCases | United States Code | Federal Courts |

Sunovion Pharmaceuticals Inc. - Comment

Document ID: FDA-2010-N-0417-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: October 29 2010, at 12:00 AM Eastern Daylight Time
Date Posted: November 12 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: August 31 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: November 1 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80b7b5bb
View Document:

This is comment on Notice

Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study of Format Variations in the Brief Summary of Direct-to-Consumer Print Advertisements

View Comment

Our comment is attached.

Attachments:

Sunovion Pharmaceuticals Inc. - Comment

Title:
Sunovion Pharmaceuticals Inc. - Comment

View Attachment:

View as format pdf

Related Comments

Total: 5

Eli Lilly and Company - Comment
Public Submission Posted: 11/12/2010 ID: FDA-2010-N-0417-0003

Comment Period Closed
Nov 01,2010 11:59 PM ET

Sunovion Pharmaceuticals Inc. - Comment
Public Submission Posted: 11/12/2010 ID: FDA-2010-N-0417-0004

Comment Period Closed
Nov 01,2010 11:59 PM ET

PhRMA - Comment
Public Submission Posted: 12/21/2010 ID: FDA-2010-N-0417-0006

Comment Period Closed
Nov 01,2010 11:59 PM ET

Bausch+Lomb - Comment
Public Submission Posted: 11/12/2010 ID: FDA-2010-N-0417-0002

Comment Period Closed
Nov 01,2010 11:59 PM ET

Maya Bermingham - Comment
Public Submission Posted: 11/12/2010 ID: FDA-2010-N-0417-0005

Comment Period Closed
Nov 01,2010 11:59 PM ET